The Development of Autoimmunity in NZB/NZW Embryonic Chimeras.

Julia Hankins,Xiaohong Li,Bruce Beutler
DOI: https://doi.org/10.4049/jimmunol.196.supp.118.7
2016-01-01
Abstract:Systemic lupus erythematosus (SLE) is an autoimmune disease resulting from autoantibodies against nuclear antigens. These autoantibodies can form complexes that sediment in joints, skin, kidneys, and vasculature to cause tissue damage, but can also cross-react with other self-antigens to induce injury. It is unclear how the immune system breaks tolerance, and in most cases, what genes or environmental factors initiate the disease. A traditional mouse model of SLE, the NZB/NZW F1, has many of the features of human SLE, including autoantibodies, nephritis, a female sex bias, as well as the complex genetic basis of the disease. Although this mouse model has proven to be useful in understanding SLE progression, it is still unknown why the F1 between two strains without SLE develop disease. To clarify the role of the two parental strains, NZB and NZW, in the development of autoimmunity we have generated NZB/NZW embryonic chimeras. These chimeras can develop autoantibodies 6 months earlier than the NZB/NZW F1 and at titers that are 10 fold greater. Furthermore, these mice also develop nephritis, the end-organ disease of SLE. Embryonic chimeras permit the study of intercellular interactions and the independent contributions of the two parental strains. Analysis has shown that most B cells are produced by NZW, and that these make autoantibodies. In addition, most T cells, and almost all activated T cells, are derived from NZB. Moreover, disease severity is associated with higher quantities of NZB T cells. Thus, understanding the pathogenesis of SLE in the NZB/NZW embryonic chimeras may elucidate possible causes of autoimmunity by identifying the intercellular transactions between these two strains that do not have SLE in isolation of one another.
What problem does this paper attempt to address?